Literature DB >> 21633332

High-throughput screening and biosensing with fluorescent C. elegans strains.

Chi K Leung1, Andrew Deonarine, Kevin Strange, Keith P Choe.   

Abstract

High-throughput screening (HTS) is a powerful approach for identifying chemical modulators of biological processes. However, many compounds identified in screens using cell culture models are often found to be toxic or pharmacologically inactive in vivo(1-2). Screening in whole animal models can help avoid these pitfalls and streamline the path to drug development. C. elegans is a multicellular model organism well suited for HTS. It is small (<1 mm) and can be economically cultured and dispensed in liquids. C. elegans is also one of the most experimentally tractable animal models permitting rapid and detailed identification of drug mode-of-action(3). We describe a protocol for culturing and dispensing fluorescent strains of C. elegans for high-throughput screening of chemical libraries or detection of environmental contaminants that alter the expression of a specific gene. Large numbers of developmentally synchronized worms are grown in liquid culture, harvested, washed, and suspended at a defined density. Worms are then added to black, flat-bottomed 384-well plates using a peristaltic liquid dispenser. Small molecules from a chemical library or test samples (e.g., water, food, or soil) can be added to wells with worms. In vivo, real-time fluorescence intensity is measured with a fluorescence microplate reader. This method can be adapted to any inducible gene in C. elegans for which a suitable reporter is available. Many inducible stress and developmental transcriptional pathways are well defined in C. elegans and GFP transgenic reporter strains already exist for many of them(4). When combined with the appropriate transgenic reporters, our method can be used to screen for pathway modulators or to develop robust biosensor assays for environmental contaminants. We demonstrate our C. elegans culture and dispensing protocol with an HTS assay we developed to monitor the C. elegans cap 'n' collar transcription factor SKN-1. SKN-1 and its mammalian homologue Nrf2 activate cytoprotective genes during oxidative and xenobiotic stress(5-10). Nrf2 protects mammals from numerous age-related disorders such as cancer, neurodegeneration, and chronic inflammation and has become a major chemotherapeutic target(11-13).Our assay is based on a GFP transgenic reporter for the SKN-1 target gene gst-4(14), which encodes a glutathione-s transferase(6). The gst-4 reporter is also a biosensor for xenobiotic and oxidative chemicals that activate SKN-1 and can be used to detect low levels of contaminants such as acrylamide and methyl-mercury(15-16).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633332      PMCID: PMC3339844          DOI: 10.3791/2745

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  17 in total

1.  Reporter transgenes for study of oxidant stress in Caenorhabditis elegans.

Authors:  Christopher D Link; Carolyn J Johnson
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

2.  Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans.

Authors:  Jennifer M A Tullet; Maren Hertweck; Jae Hyung An; Joseph Baker; Ji Yun Hwang; Shu Liu; Riva P Oliveira; Ralf Baumeister; T Keith Blackwell
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

Review 3.  Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system.

Authors:  Rock Pulak
Journal:  Methods Mol Biol       Date:  2006

4.  SKN-1/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity.

Authors:  Natalia Vanduyn; Raja Settivari; Garry Wong; Richard Nass
Journal:  Toxicol Sci       Date:  2010-09-20       Impact factor: 4.849

Review 5.  Caenorhabditis elegans: a versatile platform for drug discovery.

Authors:  Marta Artal-Sanz; Liesbeth de Jong; Nektarios Tavernarakis
Journal:  Biotechnol J       Date:  2006-12       Impact factor: 4.677

6.  Acrylamide-responsive genes in the nematode Caenorhabditis elegans.

Authors:  Koichi Hasegawa; Satsuki Miwa; Kazunori Isomura; Kaname Tsutsumiuchi; Hajime Taniguchi; Johji Miwa
Journal:  Toxicol Sci       Date:  2007-11-07       Impact factor: 4.849

7.  The WD40 repeat protein WDR-23 functions with the CUL4/DDB1 ubiquitin ligase to regulate nuclear abundance and activity of SKN-1 in Caenorhabditis elegans.

Authors:  Keith P Choe; Aaron J Przybysz; Kevin Strange
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

8.  A rapid and inexpensive method to screen for common foods that reduce the action of acrylamide, a harmful substance in food.

Authors:  Koichi Hasegawa; Satsuki Miwa; Tomoko Tajima; Kaname Tsutsumiuchi; Hajime Taniguchi; Johji Miwa
Journal:  Toxicol Lett       Date:  2007-10-07       Impact factor: 4.372

9.  Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans.

Authors:  Daniel L Chase; Judy S Pepper; Michael R Koelle
Journal:  Nat Neurosci       Date:  2004-09-19       Impact factor: 24.884

10.  Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade.

Authors:  Anton Simeonov; Ajit Jadhav; Ahmed A Sayed; Yuhong Wang; Michael E Nelson; Craig J Thomas; James Inglese; David L Williams; Christopher P Austin
Journal:  PLoS Negl Trop Dis       Date:  2008-01-02
View more
  21 in total

1.  Methods for studying the mechanisms of action of antipsychotic drugs in Caenorhabditis elegans.

Authors:  Limin Hao; Edgar A Buttner
Journal:  J Vis Exp       Date:  2014-02-04       Impact factor: 1.355

2.  SKN-1-independent transcriptional activation of glutathione S-transferase 4 (GST-4) by EGF signaling.

Authors:  Giel Detienne; Pieter Van de Walle; Wouter De Haes; Liliane Schoofs; Liesbet Temmerman
Journal:  Worm       Date:  2016-08-31

Review 3.  High-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional models.

Authors:  Natalia J Martinez; Steven A Titus; Amanda K Wagner; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2015-09-22       Impact factor: 6.098

4.  A negative-feedback loop between the detoxification/antioxidant response factor SKN-1 and its repressor WDR-23 matches organism needs with environmental conditions.

Authors:  Chi K Leung; Ying Wang; Andrew Deonarine; Lanlan Tang; Stephanie Prasse; Keith P Choe
Journal:  Mol Cell Biol       Date:  2013-07-08       Impact factor: 4.272

Review 5.  Unique structure and regulation of the nematode detoxification gene regulator, SKN-1: implications to understanding and controlling drug resistance.

Authors:  Keith P Choe; Chi K Leung; Michael M Miyamoto
Journal:  Drug Metab Rev       Date:  2012-06-04       Impact factor: 4.518

6.  In vitro and in vivo characterization of a tunable dual-reactivity probe of the Nrf2-ARE pathway.

Authors:  Rui Wang; Daniel E Mason; Keith P Choe; Alfred S Lewin; Eric C Peters; Hendrik Luesch
Journal:  ACS Chem Biol       Date:  2013-06-17       Impact factor: 5.100

Review 7.  High-throughput screening in the C. elegans nervous system.

Authors:  Holly E Kinser; Zachary Pincus
Journal:  Mol Cell Neurosci       Date:  2016-06-03       Impact factor: 4.314

8.  Genetic revelation of hexavalent chromium toxicity using Caenorhabditis elegans as a biosensor.

Authors:  Shilpi Khare Saikia; Rupali Gupta; Aakanksha Pant; Rakesh Pandey
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-10-23       Impact factor: 5.563

9.  A High-throughput, High-content, Liquid-based C. elegans Pathosystem.

Authors:  Quinton L Anderson; Alexey V Revtovich; Natalia V Kirienko
Journal:  J Vis Exp       Date:  2018-07-01       Impact factor: 1.355

10.  An ultra high-throughput, whole-animal screen for small molecule modulators of a specific genetic pathway in Caenorhabditis elegans.

Authors:  Chi K Leung; Ying Wang; Siobhan Malany; Andrew Deonarine; Kevin Nguyen; Stefan Vasile; Keith P Choe
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.